Douglas Marchuk

Douglas Marchuk

Duke University

H-index: 81

North America-United States

About Douglas Marchuk

Douglas Marchuk, With an exceptional h-index of 81 and a recent h-index of 39 (since 2020), a distinguished researcher at Duke University, specializes in the field of biology, genetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Pathologic features of brain hemorrhage after radiation treatment: case series with somatic mutation analysis

De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia

Transcriptomic signatures of individual cell types in cerebral cavernous malformation

Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in Cerebral Cavernous Malformations

mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice

Developmental expression of the Sturge–Weber syndrome-associated genetic mutation in Gnaq: a formal test of Happle's paradominant inheritance hypothesis

Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease

Familial Cerebral Cavernous Malformations

Douglas Marchuk Information

University

Position

___

Citations(all)

29685

Citations(since 2020)

6044

Cited By

26042

hIndex(all)

81

hIndex(since 2020)

39

i10Index(all)

187

i10Index(since 2020)

121

Email

University Profile Page

Google Scholar

Douglas Marchuk Skills & Research Interests

biology

genetics

Top articles of Douglas Marchuk

Pathologic features of brain hemorrhage after radiation treatment: case series with somatic mutation analysis

Journal of Stroke and Cerebrovascular Diseases

2024/7/1

De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia

Pediatric Neurology

2024/6/1

Transcriptomic signatures of individual cell types in cerebral cavernous malformation

Cell Communication and Signaling

2024/1/9

Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in Cerebral Cavernous Malformations

Nature Communications

2023/11/2

mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice

Stroke

2023/11

Developmental expression of the Sturge–Weber syndrome-associated genetic mutation in Gnaq: a formal test of Happle's paradominant inheritance hypothesis

Genetics

2023/8

Identification of the Precise Developmental Window and Tissue Bed for the Somatic Mutation Causing Sturge Weber Syndrome

2023/5/1

An analysis of sex differences in pulmonary arteriovenous malformation presentation, complications and management in a large, multinational registry of patients with hereditary …

ERJ Open Research

2023/5/1

Cardiac Troponin I–Interacting Kinase Affects Cardiomyocyte S-Phase Activity but Not Cardiomyocyte Proliferation

Circulation

2023/1/10

A novel somatic mutation in GNAQ in a capillary malformation provides insight into molecular pathogenesis

Angiogenesis

2022/11

Genetic genealogy uncovers a founder deletion mutation in the cerebral cavernous malformations 2 gene

Human genetics

2022/11

A cross-species approach using an in vivo evaluation platform in mice demonstrates that sequence variation in human RABEP2 modulates ischemic stroke outcomes

The American Journal of Human Genetics

2022/10/6

Compositions and methods for treating vascular malformation and related conditions

2022/9/27

Rapamycin in cerebral cavernous malformations: What doses to test in mice and humans

2022/4/25

Propranolol as therapy for cerebral cavernous malformations: a cautionary note

Journal of Translational Medicine

2022/4/5

Developmental venous anomalies are a genetic primer for cerebral cavernous malformations

Nature cardiovascular research

2022/3

Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia

Diabetes technology & therapeutics

2023/7/1

See List of Professors in Douglas Marchuk University(Duke University)